India’s Serum Institute faces lawsuit on Covishield vaccine over girl’s death

Serum Institute of India (SII), which produces AstraZeneca’s COVID-19 vaccine under the brand name Covishield in…

Pfizer Q3 Results: Profit declines 13.7% to ₹130 crore, revenue down 13.2% YoY

Pfizer Q3 Results: Pfizer Limited on 9 February announced the results for the third quarter of…

Pfizer Q2 results: Net profit down 52% at ₹149 crore, revenue slips 9.8%

Pharmaceutical major Pfizer on October 28 reported a net profit of ₹149 crore in the second…

Pfizer, Moderna COVID booster shots for new strains gets approval from CDC panel

Centers for Disease Control and Prevention (CDC) approved the release of COVID-19 booster shots ,on September…

Pfizer’s Updated Covid Shot Effective Against New Variant In Mice Study

EG.5 accounted for about more than 17% of COVID-19 cases in the United States. Pfizer Inc…

‘SARS-CoV-2 emerging in US, immunity levels are waning’, warns US epidemiologist

According to US epidemiologist Eric Feigl-Ding, there is evidence of SARS-CoV-2 resurging in the United States,…

Tornado damage to Pfizer plant will probably create long-term shortages of some drugs hospitals need

Debris is scattered around the Pfizer facility on July 19, 2023, in Rocky Mount, N.C., after…

Pfizer has temporarily banned the sale / distribution of its 4 antibiotics

Antibiotics – Magnex, Magnex Forte, Magnamycin and Zosyn – are all prescribed to treat different types…

Pfizer has agreed to buy Czen for $43 billion.

The drugmaker said Monday that under the terms, Pfizer would pay $229 per share in cash.…

Pfizer to buy Czen in $43 billion deal

Pfizer Inc on Monday struck a nearly $43 billion deal for CGen Inc to bolster its…